#dualitybio — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #dualitybio, aggregated by home.social.
-
BioNTech reports promising Phase II data for uterine cancer ADC
Trastuzumab pamirtecan, an investigational HER2‑targeted antibody-drug conjugate developed by BioNTech and DualityBio, has met the primary efficacy endpoint…
#Europe #EU #ADC #BioNTech #Clinicaltrials #DualityBIO #endometrialcancer #European #oncology #uterinecancer
https://www.europesays.com/europe/11565/